T1	Participants 499 558	Patients (â‰¥12 years, with ongoing seizures despite 1-3 AEDs
T2	Participants 935 1018	RESULTS Of 388 patients randomized and treated, 387 provided seizure frequency data
T3	Participants 1542 1624	Sixty-eight (17.5%) patients discontinued, including 40 (10.3%) for adverse events
